RE: Boost for investing21 Feb 2025 13:18
Yes Trench
And if people look at the AIM landscapes, even Ftse250/350 it's been tough BUT he is transforming company and as shown on 2.peeer review publications PYC name is at forefront of precision medicine
The comfort, as we've said for a ong time, is the salaries are.one of lowest ln AIM which shows they aren't using company as.gravy train like most of AIM
As you say, with £500k, a committed TR1 holder and many contracts under discussion
It's a shame there are people who just want to disrupt